Dorastine (only for R&D use), 21228-13-7, DC00100001;
Tiaramide (only for R&D use), 32527-55-2, DC00100002;
Camostat Mesilate (only for R&D use), 59721-29-8, DC00100003;
Prasugrel (only for R&D use), 150322-43-3, DC00100004;
Clevidipine butyrate, 167221-71-8, DC00100005;
Fasudil Hydrochloride, 105628-07-7, DC00100006;
Fludarabine Phosphate, 75607-67-9, DC00100007;
Granisetron Hydrochloride, 107007-99-8, DC00100008;
Flumazenil, 78755-81-4, DC00100009;
Mitoxantrone Hydrochloride, 70476-82-3 , DC00100010;
Barnidipine Hydrochloride, 104757-53-1, DC00100011;
Lercanidipine  Hydrochloride, 100427-26-9, DC00100012;
Trimetazidine dihydrochloride, 13171-25-0, DC00100013
Triphenylene 217-59-4; triethyloxonium tetrafluoroborate 368-39-8; Compound E gamma-secretase inhibitor; 4-Brommethyl-tetrahydro-pyran 125552-89-8; methyl tetrahydro-2H-pyran-4-carboxylic 110238-91-0; tetrahydro-2H-pyran-4-ylmethyl 4-methlybenzenesulfonate ; 1,1-Dioxotetrahydro-2H-thiopyran-4-one 17396-35-9; (E)-8-methyl-6-nonenoic Acid  59320-77-3; Capsaicin 404-86-4; 2,2?Azobis(2-amidinopropane) dihydrochlorid 2997-92-4; Vinylcyclohexane 695-12-5; 4-nitro-indazole  2942-40-7; Eslicarbazepine 104746-04-5; N-(tert-butoxycarbonyl)glycine N'-methoxy-N'-methylamide 121505-93-9; 9,9-Bis[4-(2-acryloyloxyethyloxy)phenyl]fluorene 161182-73-6; succinic acid mono-(2-acryloxy-ethyl) ester 50940-49-3; 1-Acetyl piperazine 13889-98-0; 3,4-Epoxycyclohexylmethyl 3,4-Epoxycyclohexane Carboxylate 2386-87-0; 3-Methyl-2-benzothiazolinone hydrazone hydrochloride hydrate 149022-15-1; 4-Fluoroindole 387-43-9; Octyl cyanoacetate 15666-97-4;  Sodium 3-(1-Naphthylamino)propanesulfonate 104484-71-1; Allyl methyl carbonate 35466-83-2; Triethyl 1,1,2-ethanetricarboxylate 7459-46-3; 1-Naphthalenemethylamine 118-31-0; 4-Methoxytriphenylmethyl chloride 14470-28-1; Diethyl chloromalonate 14064-10-9; (1S,2S)-(+)-1,2-Diaminocyclohexane 21436-03-3; (1R,2R)-(-)-1,2-Diaminocyclohexane 20439-47-8; 2-Bromomalonaldehyde 2065-75-0;